Presentations

Jan Smith: Chief Executive, Network Manager The MCN perspective

Professor Ross Lawrenson: Principal Investigator Overview of the Midlands Prostate Cancer Study

Dr Nina Scott: Chronic Conditions Advisor Inequity in Prostate Cancer

Professor Ross Lawrenson University of Auckland The management of PSA testing in general practice

Dr Zuzana Obertova  University of Auckland The management of prostate cancer in the Midland Cancer Network

Dr Charis Brown University of Auckland The impact of prostate cancer

Mhairi Porteous: Ministry of Health Improving outcomes for men with prostate cancer

Professor Ross Lawrenson Future Steps and closing

Brown C, Lawrenson R, Obertova Z, Lao C, Hodgson F, Scott N. (2013) Differences in the prostate cancer care pathway between Māori and non-Māori men in New Zealand.. 7th Annual Lakes DHB Health Research Seminar: Rotorua, New Zealand.

Lao C, Brown C, Obertová Z, Edlin R, Rouse P, Hodgson F, Holmes M, Gilling P, Lawrenson R.  The costs of identifying undiagnosed prostate cancer in asymptomatic men in NZ general practice. Waikato Biannual Research Seminar (14th March 2013).

Brown C, Lawrenson R., Obertova Z., Hodgson F. (2012) Prostate Specific Antigen Testing in Primary Care. 6th Annual Lakes DHB Health Research Seminar: Rotorua, New Zealand.

Brown, C., Lawrenson, R., Obertova, Z. (2012) Midlands Prostate Cancer Study. Ministry of Health Prostate Cancer Taskforce: Wellington, New Zealand.

Lawrenson R, Obertová Z, Hodgson F, Brown C. Management of prostate cancer in New Zealand General Practice. Royal College of GPs Conference: London (October 2013).

Obertová Z, Brown C, Hodgson F, Lawrenson R.  What do men say about diagnostic pathways? From prostate-specific antigen (PSA) test to prostate cancer. 14th Australasian Prostate Cancer Conference in Melbourne (6-10 August 2013; poster presentation). Abstract to be published in BJU International.

Obertová Z, Scott N, Brown C, Stewart A, Lawrenson R.  Survival disparities between Māori and non-Māori men with non-localised prostate cancer in New Zealand. 14th Australasian Prostate Cancer Conference in Melbourne (6-10 August 2013; oral presentation). Abstract published in BJU International.

Lawrenson R, Obertová Z, Hodgson F, Scott N, Brown C.  Screening for prostate cancer in rural men in New Zealand. 14th Australasian Prostate Cancer Conference in Melbourne (6-10 August 2013; poster presentation). Abstract published in BJU International.

Conaglen H, Brown C, Conaglen, J, Lawrenson R. The psychosocial impact of prostate cancer on couples. 14th Australasian Prostate Cancer Conference in Melbourne (6-10 August 2013; poster presentation). Abstract published in BJU International.

Conaglen H, Brown C, Conaglen, J, Lawrenson R.  Depression, anxiety and stress in men with prostate cancer: Is all well? 14th Australasian Prostate Cancer Conference in Melbourne (6-10 August 2013; oral presentation). Abstract published in BJU International.

Lawrenson R, Obertová Z, Hodgson F, Brown C. Utilisation of electronic general practice records in the Midlands Prostate Cancer Study. Oral presentation at AEA Workshop Measuring the Burden of Disease, 30 Nov 2012, University of Otago, Dunedin.

Lawrenson R, Obertová Z, Brown C, Scott N. Ethnic differences in screening rates with prostate-specific antigen (PSA) test in New Zealand general practice.  13th Australasian Prostate Cancer Conference in Melbourne (1-3 August 2012; poster presentation).

Obertová Z, Brown C, Scott N, Lawrenson R. The pathway from prostate-specific antigen (PSA) test to prostate cancer in Māori and non-Māori men in New Zealand. 13th Australasian Prostate Cancer Conference in Melbourne (1-3 August 2012; poster presentation).

Obertová Z, Lawrenson R, Scott N, Brown C. Disparities in survival rates between Māori and non-Māori men with prostate cancer in New Zealand. Population Health Congress in Adelaide (9-12 September 2012; oral presentation).

Lawrenson, R., Brown, C., Obertová, Z., Hodgson F. Midlands Prostate Cancer Study. Royal NZ College of GPs Conference: Through the patient’s eyes: Auckland, New Zealand.21-23 Sept 2012.